Opportunity ID: 282710

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-FD-16-020
Funding Opportunity Title: Therapeutic Areas for Data Standards Development (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Consumer Protection
Food and Nutrition
Health
Category Explanation:
Expected Number of Awards: 3
Assistance Listings: 93.103 — Food and Drug Administration_Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Apr 01, 2016
Last Updated Date:
Original Closing Date for Applications: Jun 03, 2016
Current Closing Date for Applications: Jun 03, 2016
Archive Date: Jul 03, 2016
Estimated Total Program Funding: $675,000
Award Ceiling: $225,000
Award Floor:

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Small businesses
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Additional Information on Eligibility: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the HHS Grants Policy Statement, are not allowed.

Additional Information

Agency Name: Food and Drug Administration
Description: Establishing common study data standards will provide new opportunities to transform the vast and continually increasing amount of clinical study data received into useful information to speed the delivery of new therapies to patients. Standardized data elements, terminologies, and data structures enable automation of important analyses of clinical study data to support more efficient and effective regulatory decision-making. In 2011, in response to an urgent need to further standardize study data terminologies and concepts for efficacy analysis, FDA’s Center for Drug Evaluation and Research (CDER) compiled a prioritized list of disease and therapeutic areas (TAs) for which additional data standardization was needed, and made the list available on the FDA website.

The primary objective of this funding opportunity is to support projects leading to the development of specifications for TAs which capture how to structure commonly collected data and outcome measurements in disease clinical trials.

Link to Additional Information: Full Funding Announcement of RFA-FD-16-020
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Bozoian

Grants Management Specialist

Phone 2404027623
Email:eric.bozoian@fda.hhs.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: Eric Bozoian
Grants Management Specialist
Phone 2404027623
Email: eric.bozoian@fda.hhs.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.103 PKG00222279 Apr 04, 2016 Jun 03, 2016 View

Package 1

Mandatory forms

282710 RR_SF424_2_0-2.0.pdf

282710 PHS398_CoverPageSupplement_3_0-3.0.pdf

282710 RR_OtherProjectInfo_1_3-1.3.pdf

282710 PerformanceSite_2_0-2.0.pdf

282710 RR_KeyPersonExpanded_2_0-2.0.pdf

282710 RR_Budget_1_3-1.3.pdf

282710 PHS398_ResearchPlan_3_0-3.0.pdf

Optional forms

282710 RR_SubawardBudget30_1_3-1.3.pdf

282710 PHS_Inclusion_Enrollment_Report-1.0.pdf

282710 PHS_AssignmentRequestForm-1.0.pdf

2025-07-09T11:41:12-05:00

Share This Post, Choose Your Platform!

About the Author: